• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Opdivo

European hedgehog Erinaceus europaeus
Marketing

BMS, Ogilvy and TANK team up for autumn melanoma campaign

Bristol Myers Squibb Canada is partnering with TANK Worldwide and Ogilvy Health on a new “What Summer Leaves Behind” skin cancer awareness campaign.
Ben Adams Nov 4, 2026 10:20am
Gavel with scales of justice in background

BMS, Ono sue Amgen over proposed Opdivo biosimilar

Sep 16, 2026 11:08am
milestone milestone pharmaceuticals

Huyabio's HDAC inhibitor scores in phase 3 melanoma study

Jul 14, 2026 10:48am
FDA Building

FDA limits Keytruda, Opdivo uses in stomach cancer

Jun 9, 2025 10:50am
Opdualag

ASCO: Bristol CMO brushes off LAG-3 concern after melanoma flop

Jun 3, 2025 8:00am
BMS

BMS follows Roche, AstraZeneca into first-line liver cancer

Apr 11, 2025 1:53pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings